Sarcopenic obesity using the ESPEN and EASO consensus statement criteria of 2022 – Results from the German KORA-Age study

The recent consensus statement of ESPEN and EASO recommends reviewing existing datasets to assess the prevalence of sarcopenic obesity based on the new definition and diagnostic criteria. Therefore, this study aimed to determine the prevalence of sarcopenic obesity in a population-based study and to...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Obesity Research & Clinical Practice Ročník 17; číslo 4; s. 349 - 352
Hlavní autoři: Schluessel, Sabine, Huemer, Marie-Theres, Peters, Annette, Drey, Michael, Thorand, Barbara
Médium: Journal Article
Jazyk:angličtina
japonština
Vydáno: Elsevier Ltd 01.07.2023
Elsevier BV
Témata:
Aging population
Bioelectrical impedance analysis
Cognitive impairment
Disability
Fat mass
Handgrip strength
Multimorbidity
Polypharmacy
Prevalence
Sarcopenic obesity
Skeletal muscle mass
Prevalence
Skeletal muscle mass
Handgrip strength
Fat mass
SMM/W
Multimorbidity
Sarcopenic obesity
Disability
Bioelectrical impedance analysis
Polypharmacy
Aging population
BIA
SO
TICS-m
BMI
WHO
Cognitive impairment
ISSN:1871-403X
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:The recent consensus statement of ESPEN and EASO recommends reviewing existing datasets to assess the prevalence of sarcopenic obesity based on the new definition and diagnostic criteria. Therefore, this study aimed to determine the prevalence of sarcopenic obesity in a population-based study and to assess the association of this new definition with clinical traits. The KORA (Cooperative Health Research in the Region of Augsburg)-Age baseline examination (2008/2009) comprised 1079 participants aged 65 years and older from southern Germany. Sarcopenic obesity was defined in 998 participants (mean age 75.6 years, 498 women) with complete data according to the 2022 ESPEN and EASO algorithm, which includes reduced handgrip strength, reduced skeletal muscle mass per weight, and elevated fat mass. Body composition was measured using bioelectrical impedance analysis. Associations between sarcopenic obesity and physical activity, disability, multimorbidity, and polypharmacy were assessed using logistic regression analysis. The overall prevalence of sarcopenic obesity was 4.5 % (5.0 % in men, 4.0 % in women). Sarcopenic obesity was associated with disability (2.87 [CI 1.84–4.48]), multimorbidity (≥ 2 comorbidities; 2.59 [CI 1.23–5.46]), polypharmacy (≥ 5 drugs; 1.96 [CI 1.05–3.63]), cognitive impairment (3.03 [CI 1.51–6.06]) and arthritis (2.66 [CI 1.39–5.07]) after adjusting for age, sex and marital status. Sarcopenic obesity is prevalent in the older German population and is associated with several clinical traits. Future longitudinal studies are needed to further elucidate whether the observed associations could be causal.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1871-403X
DOI:10.1016/j.orcp.2023.08.002